The company focuses on the R&D, production and commercialization of biopharmaceuticals, functional raw materials and health‑care foods. Leveraging its large‑scale, standardized production system and rigorous quality control system, it continuously consolidates its competitive edge in the global functional raw‑material market. Meanwhile, it is accelerating its transformation into an innovative biopharmaceutical enterprise, with strategic emphasis on cutting‑edge technology platforms including antibody drugs, ADCs and mRNA vaccines, and steadily advancing the R&D and industrialization of its biopharmaceutical pipeline.

In the biopharmaceutical sector, the Company concentrates on the R&D, production and sales of innovative biopharmaceuticals such as antibody drugs, ADCs and mRNA vaccines. Its products cover multiple therapeutic areas including oncology, autoimmune diseases and infectious diseases, forming a complete integrated industrial chain spanning “R&D‑production‑commercialization”. The Company boasts a rich portfolio of research projects. As of the end of 2025, it had more than ten key investigational drugs in clinical or late‑stage development, with multiple programs in pivotal clinical trial phases. These R&D achievements are expected to serve as key drivers for the Company’s future performance growth.

In the segment of functional raw materials and health‑care foods, core products include caffeine, acarbose, anhydrous glucose raw materials, as well as Guoweikang Vitamin C Lozenges and Vitamin B‑Complex Lozenges. Caffeine, a xanthine alkaloid compound, acts as a central nervous system stimulant that can temporarily dispel drowsiness and restore energy. It is mainly used as an additive for functional foods and beverages as well as a pharmaceutical raw material, and its application scope has expanded to cosmetics and daily‑use chemicals. Acarbose and anhydrous glucose are used as raw materials for pharmaceuticals and functional foods. As an α‑glucosidase inhibitor, acarbose effectively manages post‑prandial blood glucose levels in patients with diabetes and prediabetes by delaying carbohydrate absorption. Anhydrous glucose is widely applied in the pharmaceutical industry, where it can be formulated into oral liquids or intravenous injections as nutritional supplements. In the food industry, it can be used as a sweetener in the form of edible sugar, or as a reducing agent and a component for preparing biological culture media.

To address consumers’ diverse health needs, the Company has launched a comprehensive portfolio of health‑care products offering support for key health dimensions, such as immunity enhancement, bone mineral density improvement, anti‑oxidation, mineral supplementation and relief of visual fatigue. Catering to end‑consumers of all age groups, the Guoweikang product series covers multiple categories. Adopting advanced formulation technologies, these products deliver a refreshing taste and easy administration. They effectively supplement vitamins required by the human body and boost immunity, suitable for diverse scenarios including daily health maintenance, office alertness support and outdoor nutritional replenishment.